PRESS RELEASE published on 03/18/2024 at 10:00, 2 years 4 months ago Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada Formycon and Fresenius Kabi reach settlement agreement with Johnson & Johnson for ustekinumab biosimilar FYB202 in Europe and Canada. Agreement terms kept confidential. Focus on expanding patient access and ensuring reliable treatment options Settlement Agreement Biosimilar Formycon Fresenius Kabi Ustekinumab
PRESS RELEASE published on 03/18/2024 at 09:24, 2 years 4 months ago ESPG bond: More than 50% of bondholders have registered for written voting procedure – voting period is LIVE as of now ESPG bondholders show strong participation in written voting procedure, aiming to reach quorum. Voting period now live with key decisions to be made, encouraging all to exercise their voting rights Real Estate Bondholders Quorum ESPG Bond Voting Procedure
PRESS RELEASE published on 03/18/2024 at 09:20, 2 years 4 months ago Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings Turkiye Garanti Bankasi A.S. announces Fitch Ratings upgrade on Long-Term IDRs & Debt ratings to 'B' & 'B-', with positive outlooks Positive Outlook Turkiye Garanti Bankasi A.S. Fitch Ratings Upgrade Long-Term IDRs
PRESS RELEASE published on 03/18/2024 at 09:02, 2 years 4 months ago Original-Research: Multitude SE (von NuWays AG): BUY Multitude SE reported strong Q4 figures and reaffirmed its FY24 EBIT guidance of €67.5m. Sales increased by 15% yoy to €63.1m, driven by net loan book growth. Analyst recommends BUY with a target price of €10 Buy Recommendation Sales Growth FY24 Guidance Multitude SE Q4 Figures
PRESS RELEASE published on 03/18/2024 at 09:01, 2 years 4 months ago Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY Update on Borussia Dortmund GmbH & Co KGaA from NuWays AG highlights expected benefits from structural changes including Bundesliga broadcasting rights and new UCL format. Sponsorship upside and recent UCL success also contribute to positive outlook NuWays AG Sponsors Borussia Dortmund GmbH & Co KGaA Bundesliga UCL
PRESS RELEASE published on 03/18/2024 at 09:00, 2 years 4 months ago STAIDIUM U.S. and CALUVA Partner to Level the Playing Field in Sports Recruiting STAIDIUM U.S. partners with CALUVA to revolutionize sports recruiting by integrating AI-powered streaming technology to showcase young athletes worldwide to coaches and scouts STAIDIUM U.S. CALUVA Sports Recruiting AI-powered Streaming Technology Athlete Discovery Platform
PRESS RELEASE published on 03/18/2024 at 08:30, 2 years 4 months ago Mabilo Stage 1 Cost Update RTG Mining Inc. provides cost update for Stage 1 of the Mabilo Project in The Philippines, with Capital Costs remaining below US$25M. Operating Costs have reduced slightly, maintaining strong financials Financials Philippines RTG Mining Inc. Mabilo Project Cost Update
PRESS RELEASE published on 03/18/2024 at 08:15, 2 years 4 months ago Troy Minerals Acquires BC Property with REE Potential Troy Minerals Inc. announces the completion of staking a new property highly prospective for rare-earth elements in British Columbia. The property is unencumbered by royalties and spans 9 claims totaling 3,924.88 ha British Columbia Mineral Exploration Troy Minerals Inc. Rare-Earth Elements Property Staking
PRESS RELEASE published on 03/18/2024 at 08:12, 2 years 4 months ago Original-Research: ecotel communication ag (von Sphene Capital GmbH): Buy Sphene Capital GmbH stuft ecotel communication ag hoch und empfiehlt Kauf mit Kursziel von EUR 40,40. Analyse verdeutlicht positives Mittelfristpotenzial und deutliche Wachstumsprognosen Kaufempfehlung Wachstumspotenzial Sphene Capital GmbH Ecotel Communication AG Mittelfristprognose
PRESS RELEASE published on 03/18/2024 at 08:05, 2 years 4 months ago BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps BioNxt Solutions Inc. reports progress in toxicity and PK studies, advancing towards human comparative bioavailability studies. Development includes technology transfer, upscaling, & clinical sample prep for bioequivalence study BioNxt Solutions Inc. Toxicity Studies Comparative Pharmacokinetic Studies Bioavailability Pharmaceutical Drug Market
Published on 07/25/2026 at 00:35, 10 hours 18 minutes ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 11 hours 53 minutes ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 12 hours 38 minutes ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 12 hours 48 minutes ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 14 hours 53 minutes ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 16 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:15, 16 hours 38 minutes ago EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€
Published on 07/24/2026 at 17:50, 17 hours 2 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 18:50, 16 hours 2 minutes ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 16 hours 2 minutes ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 16 hours 30 minutes ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
Published on 07/24/2026 at 18:11, 16 hours 41 minutes ago H1 2026 liquidity contract statement for TF1